Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007

Cancer Epidemiology
R KvåleF Bray

Abstract

To compare the trends in prostate cancer incidence, treatment with curative intent and mortality across regions and counties in Norway, and to consider changes in incidence (an indicator for early diagnosis) and treatment with curative intent as explanatory factors for the decreasing prostate cancer mortality rates. Prostate cancer incidence and mortality data (1980-2007) alongside treatment data (1987-2005) were obtained from the national, population-based Cancer Registry of Norway. Joinpoint regression models were fitted to age-adjusted incidence, treatment and mortality rates to identify linear changes in the trends. Both age-adjusted incidence rates and rates of curative treatment of prostate cancer increased significantly in all five regions of Norway since the early 1990s. There was a strong positive correlation between increasing incidence and increasing use of curative treatment. The frequency of curative treatment in Western Norway was almost threefold that in the Northern and Central regions around year 2000. Subsequently, the regional trends converged and only minor differences in prostate cancer incidence and use of curative treatment were observed by 2005. The declines in mortality were observed earliest in the reg...Continue Reading

References

Jan 1, 1992·Scandinavian Journal of Urology and Nephrology·E ServollP A Høisaeter
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
May 15, 2001·International Journal of Cancer. Journal International Du Cancer·S E OliverD Gunnell
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Alan PollackIsaac Rosen
Apr 24, 2003·Health Technology Assessment : HTA·J DonovanUNKNOWN ProtecT Study Group
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Jan 29, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·T Haldorsen, T Tynes
Dec 13, 2007·Journal of the National Cancer Institute·Rune KvåleFreddie Bray
Jan 18, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ashraful HoqueXiao-Chun Xu
Jun 11, 2008·Nature Clinical Practice. Urology·Teemu J MurtolaTeuvo Lj Tammela
Jul 9, 2008·Scandinavian Journal of Urology and Nephrology·Katja FallUNKNOWN South-East Region Prostate Cancer Group

❮ Previous
Next ❯

Citations

Aug 21, 2012·BMC Medical Research Methodology·Isabelle SoerjomataramFreddie Bray
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Jun 10, 2015·European Urology·Giorgio GandagliaDavid C Miller
Dec 6, 2011·International Journal of Radiation Oncology, Biology, Physics·Wolfgang LillebyNils K Raabe
Nov 26, 2010·Journal of Neuroimmunology·Anette StorsteinChristian Vedeler
Mar 26, 2015·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Nils Kristian RaabeWolfgang Lilleby
Aug 11, 2017·International Journal of Cancer. Journal International Du Cancer·R KvåleB Møller
Mar 21, 2018·The Cochrane Database of Systematic Reviews·Venessa ChinDesmond Yip
Apr 10, 2014·Cadernos de saúde pública·Mara Beatriz Martins ConceiçãoKaren Glazer Peres

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.